J. Carmichael
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 10
- PARP inhibition in cancer therapy 5
- Colorectal Cancer Treatments and Studies 2
-
- DNA Repair Mechanisms 2
- Co-authors
- N Stuart (2 shared papers)P. A. Philip (2 shared papers)Trivadi S. Ganesan (2 shared papers)P. Thavasu (1 shared paper)Dennis Talbot (1 shared paper)Frances R. Balkwill (1 shared paper)Helaine Rockett (1 shared paper)Adrian L. Harris (2 shared papers)
- Journals
- European Journal of Cancer (4 papers)JNCI Journal of the National Cancer Institute (2 papers)Molecular Cancer Therapeutics (1 paper)Cancer Research (1 paper)Lung Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesNorway
In The Last Decade
J. Carmichael
21 papers receiving 478 citations
Peers
Comparison fields: 5 of 67
- Oncology 215
- Cancer Research 55
- Biotechnology 32
- Toxicology 11
- Biochemistry 22
Countries citing papers authored by J. Carmichael
This map shows the geographic impact of J. Carmichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Carmichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Carmichael more than expected).
Fields of papers citing papers by J. Carmichael
This network shows the impact of papers produced by J. Carmichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Carmichael. The network helps show where J. Carmichael may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Carmichael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 164 | |
| 2 | 2010 | 81 | |
| 3 | 1987 | 51 | |
| 4 | 2021 | 34 | |
| 5 | Chinese hamster pleiotropic multidrug-resistant cells are not radioresistant. | 1988 | 33 |
| 6 | 2018 | 27 | |
| 7 | 1991 | 23 | |
| 8 | 1997 | 22 | |
| 9 | 1997 | 15 | |
| 10 | 2010 | 12 | |
| 11 | A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy. | 1993 | 8 |
| 12 | 2010 | 6 | |
| 13 | 1997 | 6 | |
| 14 | 2009 | 5 | |
| 15 | 2009 | 5 | |
| 16 | 2021 | 3 | |
| 17 | 1987 | 2 | |
| 18 | 1991 | 2 | |
| 19 | 1997 | 2 | |
| 20 | 2001 | 1 |
About J. Carmichael
J. Carmichael is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Genetics, having authored 24 papers that have together received 504 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), Lung Cancer Treatments and Mutations (4 papers), Ovarian cancer diagnosis and treatment (3 papers), DNA Repair Mechanisms (2 papers), BRCA gene mutations in cancer (2 papers), Electron Spin Resonance Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Fetal and Pediatric Neurological Disorders (2 papers). The work is most often cited by research in Oncology (215 citations), Cancer Research (55 citations), Biotechnology (32 citations), Toxicology (11 citations) and Biochemistry (22 citations). J. Carmichael has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include N Stuart, P. A. Philip, Trivadi S. Ganesan, P. Thavasu, Dennis Talbot, Frances R. Balkwill, Helaine Rockett, Adrian L. Harris, Daniel Rea and George R. Pettit. Their work appears in journals such as European Journal of Cancer, JNCI Journal of the National Cancer Institute, Molecular Cancer Therapeutics, Cancer Research and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.